Need an argumentative essay on Drug Shortages Continue To Effect Patient Care. Needs to be 15 pages. Please no plagiarism.In addition, alternative sources could heighten the possibility of prescriptio

Need an argumentative essay on Drug Shortages Continue To Effect Patient Care. Needs to be 15 pages. Please no plagiarism.

In addition, alternative sources could heighten the possibility of prescription errors resulting in harmful results (ASHP 2011, para 3-4). Several of the underlying factors are incorrect product use classification, quality control issues, manufacturer problems, the regulatory authority of Food and Drug Administration (FDA), etc. Thus, this essay argues that even though there are many companies willing to produce the drugs that are in short supply, drug shortages will continue to increase and endanger patients. Overview of the Problem In a perfect setting, health care providers would be capable of constantly projecting and ordering the correct volume of drugs in a prompt way so that drug companies could manufacture adequate volumes and distributors could distribute the products in a timely way. The purpose of just-in-time (JIT) inventory method is to lessen binding substantial amount of cash for long durations and, furthermore, to minimize the cost related to inventory management. There have been numerous aspects that affect drug manufacturing (ASHP 2006, 22). At times production deficiencies arise when drug companies miscalculate the demand for products due to newly implemented treatment policies, new symptoms, changes in medical procedure, and low-quality planning. Stopping production, changes in agreement, sudden withdrawals, and marketing policies can also bring about drug shortages (ASHP 2006. 22-23). Hence, the effect that drug shortages have on pharmacies can be overwhelming and could involve a rise in drug costs as an outcome of buying non-contracted drugs which could unfavorably impact packaged product agreements (Quick et al. 1997, 13). At times, manufacturers will be incapable of supplying a pharmaceutical due to a variety of supply and demand circumstances. This might include the failure of the manufacturer to acquire raw materials, production problems associated with equipment malfunction, or plainly the failure to manufacture adequate quantities to cope with the demand. Even though adverse, drug shortages are a fact that should be addressed to prevent endangering patient care. According to the professional practice associate for the American Society of Health-System Pharmacists (ASHP), Joe Deffenbaugh, “It’s [drug shortage] a multi-faceted problem with many different owners and many different vested interests. It’s an international issue. All it takes is one glitch in taking a product from raw material to patient to create mass problems” (Gebhart 2000, 50). Out of the blue, the mass media has found out about the issue of drug shortages. *graph taken from Koh (2011, 1) The above figure illustrates the pattern in the general prevalence of drug shortages over the recent years as revealed by the FDA, and the comparative prevalence of shortages caused by sterile injectables (Koh 2011, 1). As stated in a current report, the prevalence and effect of drug shortages have increased in severity, and shortages impact every part of the health care sector. Roughly 240 drugs were either out of stock or insufficient in 2010 and roughly 400 generic counterparts were ordered several days ahead (n.a. 2011, B03).